Sistema cardiovascular

A unique collection of xnum GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target

A unique collection of 144 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS);

Regaloside C is a glycerol glucoside isolated from Lilium genus with anti-inflammatory properties.

A unique collection of 1353 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high

A unique collection of xnum cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1336 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies；

2-Hydroxybenzylamine captures IsoLGs, prevents early atrial fibrillation recurrence post-ablation.

A unique collection of xnum compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 131 cardiotoxicity inducing compounds for toxicological study;

Anti-FABP3 Antibody (7D420) is a Mouse antibody targeting FABP3. Anti-FABP3 Antibody (7D420) can be used in ELISA, WB, IHC.

Anti-GLA/alpha-Galactosidase A Antibody (3E14) is an antibody targeting GLA/alpha-Galactosidase A. Anti-GLA/alpha-Galactosidase A Antibody (3E14) can be used in ELISA, IHC, FCM.

Anti-FABP4 Antibody (6E726) is an antibody targeting FABP4. Anti-FABP4 Antibody (6E726) can be used in ELISA.

Anti-Coagulation factor X/F10 Antibody (5F696) is an antibody targeting Coagulation factor X/F10. Anti-Coagulation factor X/F10 Antibody (5F696) can be used in ELISA, IHC.

Anti-Glycophorin A Antibody (2S153) is an antibody targeting Glycophorin A. Anti-Glycophorin A Antibody (2S153) can be used in ELISA, FCM.

Anti-IL-8/CXCL8 Antibody (5C84) is a Mouse antibody targeting IL-8/CXCL8. Anti-IL-8/CXCL8 Antibody (5C84) can be used in ELISA, IHC.

Anti-Haptoglobin Antibody (4J724) is an antibody targeting Haptoglobin. Anti-Haptoglobin Antibody (4J724) can be used in ELISA, IHC.

Anti-CD9 Antibody (6U52) is an antibody targeting CD9. Anti-CD9 Antibody (6U52) can be used in ELISA, WB, IHC, IF, FCM.

Anti-CETP Antibody (2H481) is an antibody targeting CETP. Anti-CETP Antibody (2H481) can be used in ELISA, IHC.

Anti-CD9 Antibody (5F780) is a Mouse antibody targeting CD9. Anti-CD9 Antibody (5F780) can be used in ELISA, WB.

Anti-CD31 Antibody (6V47) is an antibody targeting CD31. Anti-CD31 Antibody (6V47) can be used in ELISA, WB, IHC, FCM.

Anti-SAA1 Antibody (5E204) is a Mouse antibody targeting SAA1. Anti-SAA1 Antibody (5E204) can be used in ELISA.

Anti-Phospho-PTK2 (Tyr397) Antibody (5N156) is an antibody targeting Phospho-PTK2 (Tyr397). Anti-Phospho-PTK2 (Tyr397) Antibody (5N156) can be used in ELISA, WB.

Anti-Carbonic Anhydrase 9 Antibody (8S986) is an antibody targeting Carbonic Anhydrase 9. Anti-Carbonic Anhydrase 9 Antibody (8S986) can be used in ELISA, IHC.

Anti-Serum albumin Antibody (3I761) is a Mouse antibody targeting Serum albumin. Anti-Serum albumin Antibody (3I761) can be used in ELISA, WB.

Anti-FILIP1L Antibody (3N116) is a Mouse antibody targeting FILIP1L. Anti-FILIP1L Antibody (3N116) can be used in ELISA, WB.

Anti-Phospho-PDGFRB (Tyr740) Antibody (9D509) is an antibody targeting Phospho-PDGFRB (Tyr740). Anti-Phospho-PDGFRB (Tyr740) Antibody (9D509) can be used in ELISA, WB.

Anti-CD63 Antibody (2H536) is an antibody targeting CD63. Anti-CD63 Antibody (2H536) can be used in ELISA, IHC, IF.

Anti-Osteopontin Antibody (6U756) is a Mouse antibody targeting Osteopontin. Anti-Osteopontin Antibody (6U756) can be used in ELISA, WB, IHC.

Antibody Type: Mouse Monoclonal
Application: ELISA,IHC
Reactivity: Human

Anti-AMBP Antibody (8J942) is a Mouse antibody targeting AMBP. Anti-AMBP Antibody (8J942) can be used in ELISA, IHC.

Anti-ANGPT2/Angiopoietin-2 Antibody (6U152) is an antibody targeting ANGPT2/Angiopoietin-2. Anti-ANGPT2/Angiopoietin-2 Antibody (6U152) can be used in ELISA, IHC.

Anti-AFP Antibody (2H789) is a Mouse antibody targeting AFP. Anti-AFP Antibody (2H789) can be used in ELISA, IHC.

Anti-Adiponectin Antibody (6G540) is a Mouse antibody targeting Adiponectin. Anti-Adiponectin Antibody (6G540) can be used in ELISA.

Anti-B2M/beta 2-Microglobulin Antibody (8H120) is a Mouse antibody targeting B2M/beta 2-Microglobulin. Anti-B2M/beta 2-Microglobulin Antibody (8H120) can be used in ELISA, IHC.

Anti-AFP Antibody (2P399) is a Mouse antibody targeting AFP. Anti-AFP Antibody (2P399) can be used in ELISA, IHC.

Anti-ARNT Antibody (1Z917) is an antibody targeting ARNT. Anti-ARNT Antibody (1Z917) can be used in ELISA, WB, IHC, IP.

Anti-Apolipoprotein A-II/APOA2 Antibody (4X421) is an antibody targeting Apolipoprotein A-II/APOA2. Anti-Apolipoprotein A-II/APOA2 Antibody (4X421) can be used in ELISA, WB, IHC, FCM.

Anti-RBP4 Antibody (7V2) is a Mouse antibody targeting RBP4. Anti-RBP4 Antibody (7V2) can be used in ELISA, WB, IHC.

Anti-Podoplanin Antibody (6Y710) is an antibody targeting Podoplanin. Anti-Podoplanin Antibody (6Y710) can be used in ELISA.

Anti-COX-2 Antibody (5V841) is an antibody targeting COX-2. Anti-COX-2 Antibody (5V841) can be used in ELISA.

Anti-NT5E Antibody (8O943) is an antibody targeting NT5E. Anti-NT5E Antibody (8O943) can be used in ELISA, IHC.

Anti-Myoglobin Antibody (6W871) is a Mouse antibody targeting Myoglobin. Anti-Myoglobin Antibody (6W871) can be used in ELISA, WB, IHC, IF.

Anti-TSPO Antibody (8L560) is an antibody targeting TSPO. Anti-TSPO Antibody (8L560) can be used in ELISA, WB, IHC, IF, FCM, IP.

Anti-NPPA Antibody (9Q284) is an antibody targeting NPPA. Anti-NPPA Antibody (9Q284) can be used in ELISA.

Anti-SAA1 Antibody (8H152) is an antibody targeting SAA1. Anti-SAA1 Antibody (8H152) can be used in ELISA, FCM.

Anti-MMP-9 Antibody (5B504) is an antibody targeting MMP-9. Anti-MMP-9 Antibody (5B504) can be used in ELISA, IHC, FCM.

Anti-LMO2 Antibody (3P24) is an antibody targeting LMO2. Anti-LMO2 Antibody (3P24) can be used in ELISA, WB.

Anti-NT5E Antibody (3G418) is an antibody targeting NT5E. Anti-NT5E Antibody (3G418) can be used in ELISA, IHC, FCM.

Anti-PLAU/uPA Antibody (1K616) is an antibody targeting PLAU/uPA. Anti-PLAU/uPA Antibody (1K616) can be used in ELISA, IHC.

Anti-LYVE1 Antibody (5P861) is an antibody targeting LYVE1. Anti-LYVE1 Antibody (5P861) can be used in ELISA, IF, FCM.

Anti-HAMP Antibody (7O537) is an antibody targeting HAMP. Anti-HAMP Antibody (7O537) can be used in ELISA, WB, IHC.

T0901317 is a potent and selective agonist for both LXR and FXR, with EC50 of ~50 nM and 5 μM, respectively; it inhibits nuclear factor/κB (NF/κB).

BI-0115 inhibits LOX-1, preventing oxLDL uptake by triggering receptor inhibition and dimer formation.

GSK269962A (GSK269962A HCl) is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.

Anagliptin (SK-0403) is a potent Inhibitor of DPP-4(IC50 of 3.8 nM), for the treatment of type 2 diabetes mellitus.

Dofetilide (UK 68789), a class III antiarrhythmic sulfonamide, blocks Ikr cardiac channels, prolongs action potential, and treats atrial fibrillation/flutter.

PHPS1 blocks Shp2, halts Shp2-E76K-induced Erk1/2 activation, and stops tumor cell growth.

Ethyl linoleate is a natural product and can inhibit the expression of inflammatory mediators and the development of atherosclerotic lesions.

α-Linolenic Acid (ALA) is an essential fatty acid. α-Linolenic acid improves memory, inhibits thrombosis, and lowers blood lipids. Cost-effective and quality-assured.

IMM-H007 is a novel lipid-lowering agent, increasing abca1 protein expression

PD-161570 is a potent and ATP-competitive human FGF-1 receptor inhibitor with an IC50 of 39.9 nM and a Ki of 42 nM.

GR 125743 is a novel antagonist of 5-HT1B/1D receptor.

Cynaroside (Luteolin 7-O-Glucoside) is a flavone, a flavonoid-like chemical compound. It has an anti-oxidant effect, inhibiting lipid and protein oxidation.

Delapril HCl (indalapril) is a prodrug forming two ACE inhibitors, blocking angiotensin I-II conversion.

Magnesium Lithospermate B is a derivative of caffeic acid tetramer. Magnesium Lithospermate B inhibits neuroinflammation and reduces neurodegeneration.

Emodin 6-O-β-D-glucoside (Glucoemodin) can protect barrier integrity and inhibit HMGB1-mediated inflammatory responses.

Clematichinenoside AR is anti-inflammatory, immunosuppressive, and combats arthritis via PI3K/Akt and TNF-α pathways.

N-(p-Coumaroyl) Serotonin, from safflower seeds, has antioxidant, antitumor properties and improves vascular health.

Gadolinium chloride is a calcium-sensing receptor (CaSR) agonist

Cinacalcet metabolite M4 (Rarechem AL BW 1078) is a metabolite of Cinacalcet. Cinacalcet is an allosteric agonist of Ca receptor.

Pyraclostrobin is one of the most heavily used fungicides that inhibits mitochondrial complex III of fungal and mammalian cells.

1. Loganic acid (Loganate) and geniposide exhibit both sides effect on superoxide generation.

Moexipril hydrochloride (Moexipril HCl) is a potent orally active nonsulfhydrylangiotensin converting enzyme (ACE)inhibitor, used for the treatment of

NFAT Inhibitor-2 is a compound used as a molecular building block.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Mouse ADP, and the Mouse ADP standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Mouse ADP. After TMB substrate solution is added, only those wells that contain Mouse ADP and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Mouse ADP in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human MPO, and the Human MPO standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human MPO. After TMB substrate solution is added, only those wells that contain Human MPO and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human MPO in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human Cys-C, and the Human Cys-C standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human Cys-C. After TMB substrate solution is added, only those wells that contain Human Cys-C and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Cys-C in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human CRP, and the Human CRP standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human CRP. After TMB substrate solution is added, only those wells that contain Human CRP and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human CRP in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Rat ADP, and the Rat ADP standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Rat ADP. After TMB substrate solution is added, only those wells that contain Rat ADP and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Rat ADP in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human IGFBP1, and the Human IGFBP1 standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human IGFBP1. After TMB substrate solution is added, only those wells that contain Human IGFBP1 and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human IGFBP1 in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human cTnI, and the Human cTnI standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human cTnI. After TMB substrate solution is added, only those wells that contain Human cTnI and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human cTnI in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human IL6, and the Human IL6 standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human IL6. After TMB substrate solution is added, only those wells that contain Human IL6 and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human IL6 in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human CRP, and the Human CRP standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human CRP. After TMB substrate solution is added, only those wells that contain Human CRP and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human CRP in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human MMP9, and the Human MMP9 standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human MMP9. After TMB substrate solution is added, only those wells that contain Human MMP9 and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human MMP9 in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human ADP, and the Human ADP standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human ADP. After TMB substrate solution is added, only those wells that contain Human ADP and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human ADP in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human MMP-8, and the Human MMP-8 standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human MMP-8. After TMB substrate solution is added, only those wells that contain Human MMP-8 and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human MMP-8 in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human TF, and the Human TF standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human TF. After TMB substrate solution is added, only those wells that contain Human TF and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human TF in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human BNP, and the Human BNP standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human BNP. After TMB substrate solution is added, only those wells that contain Human BNP and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human BNP in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human NT-ProBNP, and the Human NT-ProBNP standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human NT-ProBNP. After TMB substrate solution is added, only those wells that contain Human NT-ProBNP and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human NT-ProBNP in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human Lpa, and the Human Lpa standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human Lpa. After TMB substrate solution is added, only those wells that contain Human Lpa and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Lpa in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human TIMP1, and the Human TIMP1 standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human TIMP1. After TMB substrate solution is added, only those wells that contain Human TIMP1 and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human TIMP1 in the samples is then determined by comparing the OD of the samples to the standard curve.

Dacisteine (N,S-Diacetyl-L-cysteine) is an inhibitor of New Delhi metallo-beta-lactamase-1 (NDM-1, IC50 = 1000 μM).